{"id":"NCT02269241","sponsor":"Laboratories Leon Farma, S.A.","briefTitle":"Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles","officialTitle":"A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-09","primaryCompletion":"2017-10-04","completion":"2017-10-04","firstPosted":"2014-10-21","resultsPosted":"2019-07-23","lastUpdate":"2019-08-06"},"enrollment":1552,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Contraception"],"interventions":[{"type":"DRUG","name":"LF111 (drospirenone)","otherNames":["CF111"]}],"arms":[{"label":"LF111 (drospirenone)","type":"EXPERIMENTAL"}],"summary":"To demonstrate the contraceptive efficacy of LF111 . To demonstrate the safety and tolerability of LF111 and assessment of pharmacokinetics of LF111.","primaryOutcome":{"measure":"Number of Pregnancies (Evaluable Cycles)","timeFrame":"up to 13 months","effectByArm":[{"arm":"Drospirenone 4 mg","deltaMin":2.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":37,"countries":["United States"]},"refs":{"pmids":["33008401"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":1006},"commonTop":["Metrorrhagia","Headache","Dysmenorrhoea","Breast pain","Nausea"]}}